Scinovex
article Open AccessTop 10% cited

Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): Study protocol for a randomized phase II trial

BMC Cancer · 2012 · Vol. 12(1) · pp. 305–305
David A. PalmaCornelis J.A. HaasbeekGeorge RodriguesMax DaheleMichael LockBrian YaremkoRobert OlsonMitchell LiuJason PanarottoGwendolynHMJ GriffioenStewart GaedeBen J. SlotmanSuresh Senan

Abstract

Clinicaltrials.gov identifier: NCT03862911. Date of registration: March 5, 2019.

Management of metastatic bone diseaseBrain Metastases and TreatmentGlioma Diagnosis and TreatmentSABR volatility modelMedicineRadiation therapyRandomized controlled trialClinical endpointQuality of life (healthcare)OncologyInternal medicineSurgery

MeSH terms

Clinical ProtocolsHumansNeoplasm MetastasisNeoplasmsRadiosurgery

Funding

  • Ontario Institute for Cancer Research
  • Government of Ontario
Citations
307
FWCI
11.17
field-weighted impact
References
31
Percentile
99%
vs. same field & year
Citations per year
References
Long-term results of lung metastasectomy: Prognostic analyses based on 5206 cases
Journal of Thoracic and Cardiovascular Surgery · 1997 · 1,528 citations
Palliative Radiotherapy for Bone Metastases: An ASTRO Evidence-Based Guideline
International Journal of Radiation Oncology*Biology*Physics · 2011 · 846 citations
Oligometastases.
Journal of Clinical Oncology · 1995 · 2,398 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.